Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

1018.90 -3.60 (-0.35%)

25.08% Fall from 52W High

47,220 NSE+BSE Volume

NSE 03 Jun, 2025 11:38 AM (IST)

25,937.6

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Cohance Lifesciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Cohance Lifesciences Ltd. from all sources in a single place.

Load latest

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

23 Votes:

Buy 65.22%

Sell 13.04%

Hold 21.74%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >